Guanidines: Synthesis of Novel Histamine H
antagonist
breast cancer
guanidines
histamine H3 receptor
multi-target directed ligand
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
30 Apr 2023
30 Apr 2023
Historique:
received:
10
04
2023
revised:
27
04
2023
accepted:
28
04
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
This study examines the properties of novel guanidines, designed and synthesized as histamine H
Identifiants
pubmed: 37242458
pii: ph16050675
doi: 10.3390/ph16050675
pmc: PMC10223552
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Univeristy of Lodz
ID : 503/3-016-01/503-31-001-19-00
Organisme : Medical University of Lublin
ID : DS37
Organisme : Polish Smart Growth Operational Programme POIR 4.2
ID : POIR.04.02.00-00-D023/20
Références
Bioorg Med Chem Lett. 2001 Apr 9;11(7):951-4
pubmed: 11294398
Cancer Biol Ther. 2008 Jan;7(1):28-35
pubmed: 17932461
PLoS One. 2017 Oct 5;12(10):e0186108
pubmed: 28982153
ACS Chem Neurosci. 2018 May 16;9(5):1195-1214
pubmed: 29384656
Int J Mol Sci. 2018 Apr 19;19(4):
pubmed: 29671795
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6415-20
pubmed: 24140447
J Pharmacol Sci. 2005 Jan;97(1):116-23
pubmed: 15655289
Inflamm Res. 2001 Apr;50 Suppl 2:S102-3
pubmed: 11411574
Curr Med Chem. 2015;22(3):373-404
pubmed: 25386820
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):552-7
pubmed: 10598794
Molecules. 2019 Dec 06;24(24):
pubmed: 31817628
Arch Pharm (Weinheim). 2012 Aug;345(8):591-7
pubmed: 22549828
Neurology. 2010 Oct 19;75(16):1472-9
pubmed: 20956793
ACS Chem Neurosci. 2014 Mar 19;5(3):225-42
pubmed: 24422467
ACS Chem Neurosci. 2021 Jul 7;12(13):2503-2519
pubmed: 34100603
J Med Chem. 2011 Jan 13;54(1):26-53
pubmed: 21062081
Front Neurosci. 2016 May 30;10:201
pubmed: 27303254
Inflamm Allergy Drug Targets. 2010 Jul;9(3):146-57
pubmed: 20632959
Methods Find Exp Clin Pharmacol. 1992 Dec;14(10):747-51
pubmed: 1338472
Cancer Biol Ther. 2006 Nov;5(11):1462-71
pubmed: 17012845
Semin Cancer Biol. 2000 Feb;10(1):15-23
pubmed: 10888267
Arch Pharm (Weinheim). 2012 Jun;345(6):431-43
pubmed: 22415744
Leuk Lymphoma. 2000 Jan;36(3-4):367-73
pubmed: 10674909
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127522
pubmed: 32871268
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
ACS Chem Neurosci. 2015 Mar 18;6(3):438-45
pubmed: 25588572
Nat Commun. 2022 Oct 15;13(1):6105
pubmed: 36243875
Eur J Pharmacol. 2011 Mar 11;654(3):200-8
pubmed: 21237145
J Chem Inf Model. 2015 Jan 26;55(1):149-64
pubmed: 25531792
J Pharmacol Exp Ther. 2008 Aug;326(2):406-13
pubmed: 18474684
Oncotarget. 2015 Jul 10;6(19):17107-20
pubmed: 25940798
Biochem Biophys Res Commun. 2016 Nov 18;480(3):479-485
pubmed: 27773822
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58
pubmed: 13651579
J Cell Biol. 1990 Apr;110(4):1211-5
pubmed: 2182646
Inflamm Res. 2009 Apr;58 Suppl 1:55-6
pubmed: 19274436
Cancer Res. 1984 Feb;44(2):639-45
pubmed: 6692368